FDA Warning Letter Recap, April 2022
A maker of skin-care products was cited for premarket violations in the only device-related warning letter released by the US agency last month.
You may also be interested in...
Medtech Monthly is here! Check out the first episode of Medtech Insight's new podcast series: It's a knock-down (not really), drag-out (not really), freewheelin' (very much so) conversation about quality versus compliance, with the US FDA's Cisco Vicenty in one corner, and former FDA compliance chief Steve Silverman in the other.
The US FDA compliance officer says medtech manufacturers would be wise to evaluate changes to stay out of hot water with the agency.
The US FDA is teaming up with the Medical Device Innovation Consortium to establish the clearinghouse, which would nudge medtech companies to adopt novel approaches that could take their manufacturing operations to a higher level.